A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Ascending Oral Doses of AZD1656 in Japanese Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 04 Sep 2012
At a glance
- Drugs AZD 1656 (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- 04 Sep 2012 Results published in the International Journal of Clinical Pharmacology and Therapeutics.
- 18 Dec 2008 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 18 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History